N/A
N=13
Hoarding Disorder Treatment With Virtual Reality
Hoarding Disorder · Hoarding · Clutter
Bottom Line
View on ClinicalTrials.gov: NCT03828461 ↗Enrolled (actual)
13
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcome: Primary: Change in Hoarding Symptom Severity as Measured by Saving Inventory-Revised (SI-R) — 14.2 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Facilitated group therapy with behavioral practice; 16 weeks (Behavioral)
- Age
- Adult, Older Adult · 56+ yrs
- Sex
- All
- Sponsor
- Stanford University
- Primary completion
- Dec 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Hoarding Symptom Severity as Measured by Saving Inventory-Revised (SI-R) |
14.2 | — |
| SECONDARY Change in the Severity of Clutter Level as Measured by Clutter Image Rating Scale |
0.77 | — |
Summary
This study explores whether a facilitated peer support group called Buried in Treasures (BIT) and a virtual reality decluttering practice can help individuals with clutter challenges.
Eligibility Criteria
Inclusion Criteria
- Age greater than 55
- Either gender and all ethno-racial groups
- Physically healthy male or non-pregnant female.
- Hoarding Disorder primary condition
- Willing and able to understand and complete consent and study procedures
- English speaking
- Participant should have the technology to host Zoom calls
Exclusion Criteria
- Current or past history of bipolar, psychotic or eating disorders, substance dependence, or substance abuse in the last year.
- Clinically at risk of suicide with Columbia Suicide Severity Rating Scale (C-SSRS) Suicidal Ideation Subscale of 4 or higher (i.e. suicidal intent without specific plan)
- Major medical or neurological conditions that increase the risk of participation or that would prevent completing assigned behavioral practice tasks.
- Unable or unwilling to allow study staff into home for home assessment
- Currently at high risk for eviction
- Animal hoarding or squalor
Data sourced from ClinicalTrials.gov (NCT03828461). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.